Your browser doesn't support javascript.
loading
Dupilumab and tezepelumab in severe refractory asthma: new opportunities.
Ragnoli, Beatrice; Morjaria, Jaymin; Pignatti, Patrizia; Montuschi, Paolo; Barbieri, Mariangela; Mondini, Lucrezia; Ruggero, Luca; Trotta, Liliana; Malerba, Mario.
Afiliação
  • Ragnoli B; Respiratory Unit, S. Andrea Hospital, Vercelli, Italy.
  • Morjaria J; Department of Respiratory Medicine, Harefield Hospital, Guy's & St Thomas' NHS Foundation Trust, Harefield, UK.
  • Pignatti P; Allergy and Immunology Unit, Istituti Clinici Scientifici Maugeri IRCCS Pavia, Pavia, Italy.
  • Montuschi P; Pharmacology Department, Faculty of Medicine, Catholic University of the Sacred Heart, Milan, Italy.
  • Barbieri M; Respiratory Unit, S. Andrea Hospital, Vercelli, Italy.
  • Mondini L; Respiratory Unit, S. Andrea Hospital, Vercelli, Italy.
  • Ruggero L; Respiratory Unit, S. Andrea Hospital, Vercelli, Italy.
  • Trotta L; Respiratory Unit, S. Andrea Hospital, Vercelli, Italy.
  • Malerba M; Department of Translational Medicine, University of Eastern Piedmont, 28100 Novara, Italy.
Ther Adv Chronic Dis ; 13: 20406223221097327, 2022.
Article em En | MEDLINE | ID: mdl-35655942
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article